Vancomycin Administration in Peritoneal Dialysis Patients
For adults on peritoneal dialysis, vancomycin should be administered intraperitoneally using a loading dose of 15-30 mg/kg followed by maintenance doses of 15-25 mg/kg every 5-7 days, with therapeutic drug monitoring mandatory to maintain trough concentrations of 15-20 mg/L for serious infections. 1, 2
Route of Administration
Intraperitoneal administration is the preferred route for peritoneal dialysis patients, as approximately 60% of an intraperitoneal dose is absorbed systemically within 6 hours, achieving serum concentrations of approximately 10 mcg/mL with a 30 mg/kg dose 3. This route provides both local treatment for peritonitis and systemic therapeutic levels.
Dosing Regimen
Loading Dose
- Administer 15-30 mg/kg intraperitoneally as the initial loading dose 4
- Higher loading doses (20-30 mg/kg) are associated with better achievement of therapeutic targets compared to lower doses 5, 4
- For continuous ambulatory peritoneal dialysis (CAPD), a 30 mg/kg loading dose followed by 1.5-7 mg/kg maintenance dosing achieves steady-state plasma concentrations of 11-15 mg/L 4
Maintenance Dosing
- For intermittent dosing: 15-25 mg/kg intraperitoneally every 5-7 days 6
- For continuous dosing in automated peritoneal dialysis (APD): 50 mg/L in each dwell after the loading dose 5
- The pharmacokinetic half-life in peritoneal dialysis patients is markedly prolonged (66-90 hours) compared to patients with normal renal function (4-6 hours) 6, 4
Route-Specific Considerations
Intravenous vancomycin can be used as an alternative, particularly for non-peritoneal infections 7. When given IV:
- Standard dose: 15-20 mg/kg every 8-12 hours for patients with normal renal function 1
- In peritoneal dialysis patients, IV dosing requires significant adjustment due to altered clearance
- A single IV dose of 15 mg/kg produces therapeutic levels, but dosing intervals must be extended to every 5-7 days 6
Therapeutic Drug Monitoring
Trough vancomycin monitoring is mandatory for peritoneal dialysis patients 1:
- Target trough concentrations: 15-20 mg/L for serious infections (bacteremia, endocarditis, osteomyelitis, meningitis, pneumonia) 1, 2
- Measure trough levels before the fourth or fifth dose at steady state 1
- For peritoneal dialysis patients specifically, measure vancomycin levels on day 5 of treatment with subsequent dose adjustment to prevent toxic accumulation 5
Monitoring Rationale
Peritoneal dialysis patients have unique pharmacokinetic characteristics 1:
- Fluctuating volumes of distribution
- Renal dysfunction requiring dose adjustment
- CAPD clearance accounts for only 15-28% of total body clearance 7, 6
- Total vancomycin clearance is markedly reduced (approximately 6-7 mL/min vs. 48 mL/min in normal renal function) 6
Pharmacokinetic Considerations
Absorption and Distribution
- Intraperitoneal vancomycin absorption is approximately 65% 4
- Volume of distribution: 0.73 L/kg in peritoneal dialysis patients 6
- Dialysate clearance: 0.70-1.35 mL/min 7, 8, 6
- Half-life of equilibration across peritoneal membrane: 2.5 hours 8
Clearance Patterns
Vancomycin clearance varies significantly based on dialysis modality 7:
- In automated peritoneal dialysis, half-life is 11.6 hours on-cycler versus 62.8 hours off-cycler
- Renal clearance accounts for approximately 24% of total clearance
- Peritoneal dialysis clearance accounts for approximately 28% of total clearance
Common Pitfalls and Caveats
Dosing Errors
- Avoid standard 1g fixed dosing - weight-based dosing (mg/kg) produces more consistent and therapeutic serum concentrations than fixed doses 8
- Current intermittent dosing recommendations may lead to underdosing in a large proportion of patients 5
- Loading doses below 20 mg/kg are associated with sub-therapeutic concentrations 5
Timing Issues
- Shorter dosing intervals between loading and first maintenance dose are associated with supra-therapeutic concentrations 5
- For automated peritoneal dialysis patients, dosing frequency should be adjusted to once daily (15 mg/kg intraperitoneally) rather than traditional intermittent schedules 7
Monitoring Failures
- Peak vancomycin concentrations should NOT be monitored - trough concentrations are the most accurate method for guiding therapy 1
- Failure to monitor in dialysis patients can lead to either treatment failure or nephrotoxicity 1
Alternative Regimens for Specific Scenarios
For patients not responding to vancomycin or with MIC >2 mg/L, alternative agents should be considered 1:
- Linezolid 600 mg PO/IV twice daily
- Daptomycin (dose adjusted for renal function)
- High-dose daptomycin (10 mg/kg/day) in combination therapy for resistant organisms